GXP-PHARMA SUPPORT ApS: Financial statements 2018
CVR: 36033347
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
GXP-PHARMA SUPPORT ApS (CVR 36033347) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,517,034 and a net result of DKK 28,043 compared with DKK 423,986 the year before. That is an increase of 39.9% compared with the year before. Equity in the 2018 report amounted to DKK 1,099,710. The solvency ratio was 61.1%.
- Gross Profit
- DKK 1,517,034
- Profit/Loss
- DKK 28,043
- Equity
- DKK 1,099,710
- Total Assets
- DKK 1,801,323
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 1.5 mio. | 28 t. | 1.1 mio. | - |
| 2017 | - | 1.1 mio. | 424 t. | 1.9 mio. | - |
| 2016 | - | 1.5 mio. | 154 t. | 1.4 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
GXP-PHARMA SUPPORT ApS has published its annual report for 2017. Gross profit came to DKK 1,084,666, and the net result was DKK 423,986.
About GXP-PHARMA SUPPORT ApS
GXP-PHARMA SUPPORT ApS is a Danish company of the type Anpartsselskab based in Sorø, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The company was previously named GXP-PHARMA SUPPORT A/S. The management consists of Lone Cleveland Andersen. The company is owned by CHRIBEN ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 128,518 and a net result of DKK -314,498 compared with DKK -166,431 the year before. Equity in the 2025 report amounted to DKK 58,748.